Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044359888> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W3044359888 endingPage "542" @default.
- W3044359888 startingPage "539" @default.
- W3044359888 abstract "CYP2D6 is a highly polymorphic metabolic enzyme with more than 100 genetic variants, some of which are associated with significantly altered enzyme activity, such as CYP2D6.2 (Arg296Cys, Ser486Thr), CYP2D6.10 (Pro34Ser, Ser486Thr), and CYP2D6.39 (Ser486Thr). Gefitinib is a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR) and is used to treat non-small-cell lung cancer with EGFR mutations. Gefitinib is known to competitively inhibit CYP2D6 activity. The aim of this study was to quantitatively compare the inhibitory effects of gefitinib on CYP2D6 enzyme kinetics among CYP2D6 variants.The enzymatic activity of several CYP2D6 genetic variants; i.e., CYP2D6.1 (wild type), CYP2D6.2, CYP2D6.10, and CYP2D6.39, was assessed by examining the O-demethylation of dextromethorphan.The intrinsic clearance of dextromethorphan (Vmax/Km) for CYP2D6.2, CYP2D6.10, and CYP2D6.39 were 0.565-, 0.0376-, and 0.470-fold of that for wild type, respectively. For all variants, the mixed inhibition model was better at explaining the nature of the inhibitory effects of gefitinib than the competitive inhibition model. However, the inhibitory potency of gefitinib varied among the CYP2D6 genetic variants. The Ki values for CYP2D6.2, CYP2D6.10, and CYP2D6.39 were 1.4-, 2.5- and 1.5-fold higher than that for wild type, respectively, implying that these variants are less susceptible to the inhibition by gefitinib. The genetic variations in CYP2D6 might be one of the factors responsible for inter-individual differences in the strength of CYP2D6-mediated drug interactions involving gefitinib." @default.
- W3044359888 created "2020-07-29" @default.
- W3044359888 creator A5038663736 @default.
- W3044359888 creator A5046902025 @default.
- W3044359888 creator A5070909512 @default.
- W3044359888 creator A5072216758 @default.
- W3044359888 creator A5083676687 @default.
- W3044359888 date "2020-10-01" @default.
- W3044359888 modified "2023-09-25" @default.
- W3044359888 title "Profile of the inhibitory effects of gefitinib on CYP2D6 variants in vitro" @default.
- W3044359888 doi "https://doi.org/10.5414/cp203698" @default.
- W3044359888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32691726" @default.
- W3044359888 hasPublicationYear "2020" @default.
- W3044359888 type Work @default.
- W3044359888 sameAs 3044359888 @default.
- W3044359888 citedByCount "1" @default.
- W3044359888 countsByYear W30443598882022 @default.
- W3044359888 crossrefType "journal-article" @default.
- W3044359888 hasAuthorship W3044359888A5038663736 @default.
- W3044359888 hasAuthorship W3044359888A5046902025 @default.
- W3044359888 hasAuthorship W3044359888A5070909512 @default.
- W3044359888 hasAuthorship W3044359888A5072216758 @default.
- W3044359888 hasAuthorship W3044359888A5083676687 @default.
- W3044359888 hasConcept C170493617 @default.
- W3044359888 hasConcept C181199279 @default.
- W3044359888 hasConcept C2779438470 @default.
- W3044359888 hasConcept C2780580887 @default.
- W3044359888 hasConcept C2781245242 @default.
- W3044359888 hasConcept C33664856 @default.
- W3044359888 hasConcept C526171541 @default.
- W3044359888 hasConcept C55493867 @default.
- W3044359888 hasConcept C86803240 @default.
- W3044359888 hasConcept C98274493 @default.
- W3044359888 hasConceptScore W3044359888C170493617 @default.
- W3044359888 hasConceptScore W3044359888C181199279 @default.
- W3044359888 hasConceptScore W3044359888C2779438470 @default.
- W3044359888 hasConceptScore W3044359888C2780580887 @default.
- W3044359888 hasConceptScore W3044359888C2781245242 @default.
- W3044359888 hasConceptScore W3044359888C33664856 @default.
- W3044359888 hasConceptScore W3044359888C526171541 @default.
- W3044359888 hasConceptScore W3044359888C55493867 @default.
- W3044359888 hasConceptScore W3044359888C86803240 @default.
- W3044359888 hasConceptScore W3044359888C98274493 @default.
- W3044359888 hasIssue "10" @default.
- W3044359888 hasLocation W30443598881 @default.
- W3044359888 hasLocation W30443598882 @default.
- W3044359888 hasOpenAccess W3044359888 @default.
- W3044359888 hasPrimaryLocation W30443598881 @default.
- W3044359888 hasRelatedWork W2000782600 @default.
- W3044359888 hasRelatedWork W2031205523 @default.
- W3044359888 hasRelatedWork W2051877339 @default.
- W3044359888 hasRelatedWork W2055102246 @default.
- W3044359888 hasRelatedWork W2074989130 @default.
- W3044359888 hasRelatedWork W2092796573 @default.
- W3044359888 hasRelatedWork W2095195769 @default.
- W3044359888 hasRelatedWork W2323193158 @default.
- W3044359888 hasRelatedWork W2768889679 @default.
- W3044359888 hasRelatedWork W3044359888 @default.
- W3044359888 hasVolume "58" @default.
- W3044359888 isParatext "false" @default.
- W3044359888 isRetracted "false" @default.
- W3044359888 magId "3044359888" @default.
- W3044359888 workType "article" @default.